APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meningitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Meningitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025185 pages

Choose your research edition.

Industry ResearchMeningitis Vaccine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Meningitis Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Meningitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meningitis Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Meningitis Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Meningitis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Meningitis Vaccine include Zhejiang Tianyuan, Sanofi Pasteur, Novartis, Merck, Pfizer, GlaxoSmithKline, Beijing Tiantan Biological, Baxter International and Hualan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Meningitis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Meningitis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Meningitis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Meningitis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Meningitis Vaccine Segment by Company

Zhejiang Tianyuan

Sanofi Pasteur

Novartis

Merck

Pfizer

GlaxoSmithKline

Beijing Tiantan Biological

Baxter International

Hualan

Meningitis Vaccine Segment by Type

Meningitis A+C

Meningitis ACWY135

Meningitis B

Meningitis Vaccine Segment by Application

Medical Care

Hospital

Meningitis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meningitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meningitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meningitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Meningitis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meningitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Meningitis Vaccine Industry Trends Table 2. Meningitis Vaccine Industry Drivers Table 3. Meningitis Vaccine Industry Opportunities and Challenges Table 4. Meningitis Vaccine Industry Restraints Table 5. Global Meningitis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Meningitis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Meningitis Vaccine Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Meningitis Vaccine Sales Market Share by Manufacturers Table 9. Global Meningitis Vaccine Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Meningitis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Meningitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Meningitis Vaccine Manufacturers, Product Type & Application Table 13. Global Meningitis Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Meningitis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Meningitis A+C Table 17. Major Manufacturers of Meningitis ACWY135 Table 18. Major Manufacturers of Meningitis B Table 19. Global Meningitis Vaccine Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 20. Global Meningitis Vaccine Sales by Type (2021-2026) & (W Tons) Table 21. Global Meningitis Vaccine Sales by Type (2027-2032) & (W Tons) Table 22. Global Meningitis Vaccine Sales Market Share by Type (2021-2026) Table 23. Global Meningitis Vaccine Sales Market Share by Type (2027-2032) Table 24. Global Meningitis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 25. Global Meningitis Vaccine Revenue by Type (2021-2026) & (W Tons) Table 26. Global Meningitis Vaccine Revenue by Type (2027-2032) & (W Tons) Table 27. Global Meningitis Vaccine Revenue Market Share by Type (2021-2026) Table 28. Global Meningitis Vaccine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Medical Care Table 30. Major Manufacturers of Hospital Table 31. Global Meningitis Vaccine Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 32. Global Meningitis Vaccine Sales by Application (2021-2026) & (W Tons) Table 33. Global Meningitis Vaccine Sales by Application (2027-2032) & (W Tons) Table 34. Global Meningitis Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Meningitis Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Meningitis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 37. Global Meningitis Vaccine Revenue by Application (2021-2026) & (W Tons) Table 38. Global Meningitis Vaccine Revenue by Application (2027-2032) & (W Tons) Table 39. Global Meningitis Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Meningitis Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Meningitis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 42. Global Meningitis Vaccine Sales by Region (2021-2026) & (W Tons) Table 43. Global Meningitis Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Meningitis Vaccine Sales Forecasted by Region (2027-2032) & (W Tons) Table 45. Global Meningitis Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 47. North America Meningitis Vaccine Sales by Country (2021-2026) & (W Tons) Table 48. North America Meningitis Vaccine Sales by Country (2027-2032) & (W Tons) Table 49. Europe Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 50. Europe Meningitis Vaccine Sales by Country (2021-2026) & (W Tons) Table 51. Europe Meningitis Vaccine Sales by Country (2027-2032) & (W Tons) Table 52. Asia Pacific Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 53. Asia Pacific Meningitis Vaccine Sales by Country (2021-2026) & (W Tons) Table 54. Asia Pacific Meningitis Vaccine Sales by Country (2027-2032) & (W Tons) Table 55. South America, Middle East and Africa Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 56. South America, Middle East and Africa Meningitis Vaccine Sales by Country (2021-2026) & (W Tons) Table 57. South America, Middle East and Africa Meningitis Vaccine Sales by Country (2027-2032) & (W Tons) Table 58. Global Meningitis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Meningitis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Meningitis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Meningitis Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Meningitis Vaccine Revenue Market Share by Region (2027-2032) Table 63. Zhejiang Tianyuan Company Information Table 64. Zhejiang Tianyuan Business Overview Table 65. Zhejiang Tianyuan Meningitis Vaccine Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zhejiang Tianyuan Meningitis Vaccine Product Portfolio Table 67. Zhejiang Tianyuan Recent Development Table 68. Sanofi Pasteur Company Information Table 69. Sanofi Pasteur Business Overview Table 70. Sanofi Pasteur Meningitis Vaccine Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanofi Pasteur Meningitis Vaccine Product Portfolio Table 72. Sanofi Pasteur Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Meningitis Vaccine Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Novartis Meningitis Vaccine Product Portfolio Table 77. Novartis Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Meningitis Vaccine Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Merck Meningitis Vaccine Product Portfolio Table 82. Merck Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Meningitis Vaccine Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Meningitis Vaccine Product Portfolio Table 87. Pfizer Recent Development Table 88. GlaxoSmithKline Company Information Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Meningitis Vaccine Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Meningitis Vaccine Product Portfolio Table 92. GlaxoSmithKline Recent Development Table 93. Beijing Tiantan Biological Company Information Table 94. Beijing Tiantan Biological Business Overview Table 95. Beijing Tiantan Biological Meningitis Vaccine Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Beijing Tiantan Biological Meningitis Vaccine Product Portfolio Table 97. Beijing Tiantan Biological Recent Development Table 98. Baxter International Company Information Table 99. Baxter International Business Overview Table 100. Baxter International Meningitis Vaccine Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Baxter International Meningitis Vaccine Product Portfolio Table 102. Baxter International Recent Development Table 103. Hualan Company Information Table 104. Hualan Business Overview Table 105. Hualan Meningitis Vaccine Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Hualan Meningitis Vaccine Product Portfolio Table 107. Hualan Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Meningitis Vaccine Distributors List Table 111. Meningitis Vaccine Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Meningitis Vaccine Product Image Figure 2. Global Meningitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meningitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Meningitis Vaccine Sales (2021-2032) & (W Tons) Figure 5. Global Meningitis Vaccine Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Meningitis Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Meningitis A+C Image Figure 9. Meningitis ACWY135 Image Figure 10. Meningitis B Image Figure 11. Global Meningitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 12. Global Meningitis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Meningitis Vaccine Sales Market Share by Type (2021-2032) Figure 14. Global Meningitis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 15. Global Meningitis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Meningitis Vaccine Revenue Market Share by Type (2021-2032) Figure 17. Medical Care Image Figure 18. Hospital Image Figure 19. Global Meningitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 20. Global Meningitis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Meningitis Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Meningitis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 23. Global Meningitis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Meningitis Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 26. North America Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 28. Canada Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. Mexico Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 30. Europe Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 31. Europe Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 33. France Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. U.K. Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 35. Italy Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. Netherlands Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. Asia Pacific Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 38. Asia Pacific Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 40. Japan Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. South Korea Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 42. Southeast Asia Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. India Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. Australia Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. South America, Middle East and Africa Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 46. South America, Middle East and Africa Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 48. South Africa Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. Saudi Arabia Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 50. Turkey Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. Argentina Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. UAE Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. Egypt Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Chile Meningitis Vaccine Sales and Growth Rate (2021-2032) & (W Tons) Figure 55. Global Meningitis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Meningitis Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Meningitis Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Meningitis Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Meningitis A+C
  • Meningitis ACWY135
  • Meningitis B
Applications
  • Medical Care
  • Hospital
Companies covered
  • Zhejiang Tianyuan
  • Sanofi Pasteur
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Beijing Tiantan Biological
  • Baxter International
  • Hualan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Meningitis Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Meningitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Meningitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Meningitis Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Meningitis Vaccine Market Dynamics
  1. 2.1 Meningitis Vaccine Industry Trends
  2. 2.2 Meningitis Vaccine Industry Drivers
  3. 2.3 Meningitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Meningitis Vaccine Industry Restraints
3 Meningitis Vaccine Market by Manufacturers
  1. 3.1 Global Meningitis Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Meningitis Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Meningitis Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Meningitis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Meningitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Meningitis Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Meningitis Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Meningitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Meningitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Meningitis Vaccine Tier 1, Tier 2, and Tier 3
4 Meningitis Vaccine Market by Type
  1. 4.1 Meningitis Vaccine Type Introduction
  2. 4.1.1 Meningitis A+C
  3. 4.1.2 Meningitis ACWY135
  4. 4.1.3 Meningitis B
  5. 4.2 Global Meningitis Vaccine Sales by Type
  6. 4.2.1 Global Meningitis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Meningitis Vaccine Sales by Type (2021-2032)
  8. 4.2.3 Global Meningitis Vaccine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Meningitis Vaccine Revenue by Type
  10. 4.3.1 Global Meningitis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Meningitis Vaccine Revenue by Type (2021-2032)
  12. 4.3.3 Global Meningitis Vaccine Revenue Market Share by Type (2021-2032)
5 Meningitis Vaccine Market by Application
  1. 5.1 Meningitis Vaccine Application Introduction
  2. 5.1.1 Medical Care
  3. 5.1.2 Hospital
  4. 5.2 Global Meningitis Vaccine Sales by Application
  5. 5.2.1 Global Meningitis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Meningitis Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Meningitis Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Meningitis Vaccine Revenue by Application
  9. 5.3.1 Global Meningitis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Meningitis Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Meningitis Vaccine Revenue Market Share by Application (2021-2032)
6 Global Meningitis Vaccine Sales by Region
  1. 6.1 Global Meningitis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Meningitis Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Meningitis Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Meningitis Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Meningitis Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Meningitis Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Meningitis Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Meningitis Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Meningitis Vaccine Revenue by Region
  1. 7.1 Global Meningitis Vaccine Revenue by Region
  2. 7.1.1 Global Meningitis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Meningitis Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Meningitis Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Meningitis Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Meningitis Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Meningitis Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Meningitis Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Meningitis Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Tianyuan
  2. 8.1.1 Zhejiang Tianyuan Company Information
  3. 8.1.2 Zhejiang Tianyuan Business Overview
  4. 8.1.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Tianyuan Meningitis Vaccine Product Portfolio
  6. 8.1.5 Zhejiang Tianyuan Recent Developments
  7. 8.2 Sanofi Pasteur
  8. 8.2.1 Sanofi Pasteur Company Information
  9. 8.2.2 Sanofi Pasteur Business Overview
  10. 8.2.3 Sanofi Pasteur Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pasteur Meningitis Vaccine Product Portfolio
  12. 8.2.5 Sanofi Pasteur Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Meningitis Vaccine Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Meningitis Vaccine Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Meningitis Vaccine Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Meningitis Vaccine Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Beijing Tiantan Biological
  38. 8.7.1 Beijing Tiantan Biological Company Information
  39. 8.7.2 Beijing Tiantan Biological Business Overview
  40. 8.7.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Tiantan Biological Meningitis Vaccine Product Portfolio
  42. 8.7.5 Beijing Tiantan Biological Recent Developments
  43. 8.8 Baxter International
  44. 8.8.1 Baxter International Company Information
  45. 8.8.2 Baxter International Business Overview
  46. 8.8.3 Baxter International Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Baxter International Meningitis Vaccine Product Portfolio
  48. 8.8.5 Baxter International Recent Developments
  49. 8.9 Hualan
  50. 8.9.1 Hualan Company Information
  51. 8.9.2 Hualan Business Overview
  52. 8.9.3 Hualan Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hualan Meningitis Vaccine Product Portfolio
  54. 8.9.5 Hualan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Meningitis Vaccine Value Chain Analysis
  2. 9.1.1 Meningitis Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Meningitis Vaccine Production Mode & Process
  6. 9.2 Meningitis Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Meningitis Vaccine Distributors
  9. 9.2.3 Meningitis Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst